NCT04301609View on ClinicalTrials.gov

Clinical Trial to Assess the Improvement of Fatigue, Sleep Problems, Anxiety / Depression, Neurovegetatives Alterations and Quality of Life After the Administration of ImmunoVita® in Chronic Fatigue Syndrome Patients

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

December 30, 2022

Study Completion Date

January 31, 2023

Conditions
Chronic Fatigue SyndromeMyalgic Encephalomyelitis
Interventions
DIETARY_SUPPLEMENT

Active

Take 4 capsules daily (2 capsules on an empty stomach + 2 capsules 30 minutes before dinner).

DIETARY_SUPPLEMENT

Placebo

Take 4 capsules daily (2 capsules on an empty stomach + 2 capsules 30 minutes before dinner).

Trial Locations (1)

08035

Hospital Vall d'Hebron, Barcelona

All Listed Sponsors
collaborator

Hospital Vall d'Hebron

OTHER

lead

Vitae Health Innovation

INDUSTRY

NCT04301609 - Clinical Trial to Assess the Improvement of Fatigue, Sleep Problems, Anxiety / Depression, Neurovegetatives Alterations and Quality of Life After the Administration of ImmunoVita® in Chronic Fatigue Syndrome Patients | Biotech Hunter | Biotech Hunter